本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-005092 Act: 33 Size: 586 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 8.01 Accession Number: 0001683168-24-005049 Act: 34 Size: 198 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001123292-24-000200 Act: 33 Size: 10 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001683168-24-004800 Act: 34 Size: 593 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.02, 8.01, and 9.01 Accession Number: 0001683168-24-004683 Act: 34 Size: 211 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001683168-24-004619 Act: 34 Size: 245 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002034 Act: 33 Size: 1 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001683168-24-004417 Act: 34 Size: 397 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004126 Size: 4 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004089 Size: 4 KB 网页链接